$A - Healthcare | Diagnostics & Research
Low ADR, but the multi year long uptrend along with its consistent YoY EPS and sales growth makes this an interesting growth name to be in the WL
latest ER have $A gapped above its 200MA and AVWAP from ATH. actionable trade at $150 imo
Low ADR, but the multi year long uptrend along with its consistent YoY EPS and sales growth makes this an interesting growth name to be in the WL
latest ER have $A gapped above its 200MA and AVWAP from ATH. actionable trade at $150 imo
免責聲明
這些資訊和出版物並非旨在提供,也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。
免責聲明
這些資訊和出版物並非旨在提供,也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。
